TELA Bio (TELA) Cash from Financing Activities (2018 - 2026)
TELA Bio's quarterly Cash from Financing Activities came in at -$298000.0 in Q1 2026, down 156.9% year-on-year from $523757.6 in Q1 2025, and down 101.15% quarter-over-quarter from $25.8 million in Q4 2025.
TELA Bio has reported Cash from Financing Activities for 9 years, with the latest figure at -$298000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 156.9% year-over-year to -$298000.0; the trailing twelve-month figure through Mar 2026 stood at $25.6 million (down 40.38% YoY), and the FY2025 full-year result was $25.8 million, down 40.2% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$298000.0, down from $25.8 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $46.4 million in Q2 2023, with the low at -$298000.0 in Q1 2026.
- Average Cash from Financing Activities over 5 years is $9.2 million, with a median of $24000.0 recorded in 2025.
- Year-over-year, Cash from Financing Activities slumped 505.56% in 2022 and jumped 194936.36% in 2024.
- Tracing TELA's Cash from Financing Activities over 5 years: stood at -$219000.0 in 2022, then soared by 110.05% to $22000.0 in 2023, then jumped by 194936.36% to $42.9 million in 2024, then plunged by 39.77% to $25.8 million in 2025, then plunged by 101.15% to -$298000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$298000.0 (Q1 2026), $25.8 million (Q4 2025), and $24000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | -298,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -298,000.00 |
| Mar 31, 2026 | -298,000.00 |
| Dec 31, 2025 | 25.85 Mn |
| Dec 31, 2025 | 25.85 Mn |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -116,000.00 |
| Mar 31, 2025 | -116,000.00 |
| Dec 31, 2024 | 42.91 Mn |
| Dec 31, 2024 | 42.91 Mn |
| Sep 30, 2024 | 98,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 71,000.00 |
| Sep 30, 2023 | 71,000.00 |
| Jun 30, 2023 | 46.41 Mn |
| Jun 30, 2023 | 46.41 Mn |
| Mar 31, 2023 | -235,000.00 |
| Mar 31, 2023 | -235,000.00 |
| Dec 31, 2022 | -219,000.00 |
| Dec 31, 2022 | -219,000.00 |
| Sep 30, 2022 | 34.57 Mn |
| Sep 30, 2022 | 34.57 Mn |
| Jun 30, 2022 | 6.65 Mn |
| Jun 30, 2022 | 6.65 Mn |
| Mar 31, 2022 | -146,000.00 |
| Mar 31, 2022 | -146,000.00 |
| Dec 31, 2021 | 174,000.00 |
| Dec 31, 2021 | 174,000.00 |
| Sep 30, 2021 | 259,000.00 |
| Sep 30, 2021 | 259,000.00 |
| Jun 30, 2021 | 116,000.00 |
| Jun 30, 2021 | 116,000.00 |
| Mar 31, 2021 | 36,000.00 |
| Mar 31, 2021 | 36,000.00 |
| Dec 31, 2020 | 46,000.00 |
| Dec 31, 2020 | 46,000.00 |
| Sep 30, 2020 | -279,000.00 |
| Sep 30, 2020 | -279,000.00 |
| Jun 30, 2020 | 45.16 Mn |
| Jun 30, 2020 | 45.16 Mn |
| Mar 31, 2020 | -514,000.00 |
| Mar 31, 2020 | -514,000.00 |
| Dec 31, 2019 | 51.11 Mn |
| Dec 31, 2019 | 51.11 Mn |
| Sep 30, 2019 | 2.26 Mn |
| Sep 30, 2019 | 2.26 Mn |
| Jun 30, 2019 | 11.68 Mn |
| Jun 30, 2019 | 11.68 Mn |
| Mar 31, 2019 | 484,000.00 |
| Mar 31, 2019 | 484,000.00 |
| Dec 31, 2018 | 22.65 Mn |
| Dec 31, 2018 | 22.65 Mn |